<DOC>
	<DOCNO>NCT00282386</DOCNO>
	<brief_summary>This study compare effect 156 week treatment MK-0966 ( Rofecoxib ) versus placebo recurrence colorectal adenoma ( growths occur inside ( line ) large intestine , also know colon ) patient history colorectal adenoma .</brief_summary>
	<brief_title>A Study Evaluate Effect MK0966 ( Rofecoxib ) Recurrence Colorectal Adenomas ( 0966-122 )</brief_title>
	<detailed_description />
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Adenoma</mesh_term>
	<mesh_term>Rofecoxib</mesh_term>
	<criteria>Eligible patient must undergo complete colonoscopy within 12 week study entry removal polyp ; least one polyp must confirm large bowel precancerous polyp ( adenoma ) study pathologist . History specific hereditary large bowel polyp syndrome History large bowel adenoma age 35 Small large bowel resection history inflammatory bowel disease History cancer within five year enrollment Expected need chronic NSAID therapy Positive test result stool occult blood Uncontrolled hypertension , stroke temporary mini stroke ( TIA ) within past 2 year , angina congestive heart failure symptom occur rest minimal activity History myocardial infarction ( heart attack ) , coronary angioplasty , coronary artery bypass graft within past 1 year Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>